Werewolf Therapeutics Inc (HOWL) — Financial Flexibility Index
Werewolf Therapeutics Inc (HOWL) has a Financial Flexibility Index of -0.23x as of March 2026. Free cash flow of $-10.60 Million (operating CF $-10.60 Million minus capex $0.00) represents 0% of total liabilities ($45.82 Million). Check Werewolf Therapeutics Inc (HOWL) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Werewolf Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Werewolf Therapeutics Inc across 7 annual periods. See Werewolf Therapeutics Inc (HOWL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Werewolf Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Werewolf Therapeutics Inc. For the full company profile including market capitalisation, see Werewolf Therapeutics Inc (HOWL) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.35x | $-60.29 Million | $-60.29 Million | $44.59 Million | ▼ -29.4% |
| 2024 | -1.04x | $-55.93 Million | $-56.19 Million | $53.54 Million | ▼ -108.2% |
| 2023 | -0.50x | $-31.84 Million | $-32.61 Million | $63.46 Million | ▲ +48.6% |
| 2022 | -0.98x | $-36.98 Million | $-40.60 Million | $37.91 Million | ▲ +39.1% |
| 2021 | -1.60x | $-42.38 Million | $-42.88 Million | $26.46 Million | ▲ +36.4% |
| 2020 | -2.52x | $-18.06 Million | $-18.62 Million | $7.18 Million | ▼ -223.1% |
| 2019 | -0.78x | $-9.28 Million | $-9.54 Million | $11.91 Million | — |